Treatments for lower urinary tract symptoms due to benign prostatic hyperplasia can be evaluated by multiple metrics. A balance within the confines of patient expectations is key to determining the ideal treatment. A troubling adverse event for some patients is sexual dysfunction. Because the cohort of men who seek treatment of sexual dysfunction and lower urinary tract symptoms is essentially identical, these disease processes frequently overlap. This article considers potential pathophysiologic causes of dysfunction with treatment and attempts to critically review the available data to assess the true incidence of sexual adverse events with treatment.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.ucl.2016.04.010 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!